Performance of subcutaneously implanted glucose sensors: A review

Journal of Investigative Surgery

Volumn 11, Issue 3, 1998, Pages 163-174

  Gerritsen, Martijn ^a   Jansen, John A ^a,b   Kros, Alexander ^a   Nolte, Roeland J M ^a   Lutterman, Jos A ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Continuous glucose sensing; Implantable glucose sensor; Subcutaneous tissue

Indexed keywords

GLUCOSE; OXYGEN;

ANIMAL EXPERIMENT; BLOOD GLUCOSE MONITORING; CALIBRATION; DIABETES MELLITUS; ENZYME ELECTRODE; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HUMAN; IMPLANT; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; REVIEW; SENSOR; SUBCUTANEOUS TISSUE; WOUND HEALING IMPAIRMENT;

EID: 0031694505     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.3109/08941939809098031     Document Type: Review

References (83)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Eggins B. Biosensors: An Introduction. Chichester: Wiley and Teubner; 1996.
3. Black J. Biological Performance of Materials, Fundamentals of Biocompatibility. 2nd ed. New York: Marcel Dekker; 1992.
4. Wilkins E, Atanasov P. Glucose monitoring: state of the art and future possibilities. Med Eng Phys. 1996;18(4):273-288.
5. Pickup JC, Thevenot DR. European achievements in sensor research dedicated to in vivo monitoring. In Advances in Biosensors, supplement 1. London: JAI Press, 1993:201-225.
6. Pickup JC. In vivo glucose monitoring: sense and sensorbility. Diabetes Care. 1993;16(2):535-539.
7. Kyrolainen M, Rigsby P, Eddy S, Vadgama P. Bio-/ haemocompatibility: implications and outcomes for sensors? Acta Anaesthesiol Scand. 1995;39(suppl.104):55-60.
8. Koudelka M, Rohner-Jeanrenaud F, Terrettaz J, Bobbioni-Harsch E, de Rooij NF, Jeanrenaud B. In vivo behaviour of hypodermically implanted microfabricated glucose sensors. Biosens Bioelectr. 1991;6:31-36.
9. Ward WK, Wilgus W, Troupe JE. Rapid detection of hyperglycaemia by a subcutaneously implanted glucose sensor in the rat. Biosens Bioelectr. 1994;9:423-428.
10. Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D. Enzymatic glucose sensors: improved long-term performance in vitro and in vivo. ASAIO J. 1994;40:157-163.
11. Gilligan BJ, Shults MC, Rhodes RK, Updike SJ. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care. 1994;17:882-887.
12. Shults MC, Rhodes RK, Updike SJ, Gilligan BJ. Reining WN. A telemetry-instrumentation system for monitoring multiple subcutaneously implanted glucose sensors. IEEE Trans Biomed Eng. 1994;41:937-942.
13. Wilkins E, Atanasov P. Integrated implantable device for long-term glucose monitoring. Biosens Bioelectr. 1995;10:485-494.
14. Moussy F, Harrison DJ, Rajotte RV. A miniaturized Nafion-based glucose sensor: in vitro and in vivo evaluation in dogs. Int J Artif Organs. 1994;17:88-94.
15. Moussy F, Harrison DJ, O'Brein DW, Rajotte RV. Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem. 1993;65:2072-2077.
16. Moussy F, Jakeway S, Harrison JD, Rajotte RV. In vitro and in vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing. Anal Chem. 1994;66:3882-3888.
17. Ertefai S, Gough DA. Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensors. J Biomed Eng. 1989;11:362-368.
18. Cammann K. Implantable electrochemical glucose sensors: state of the art. Horm Metab Res Suppl. 1988;20:4-8.
19. Gough DA, Armour JC. Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes. 1995;44:1005-1009.
20. Wilkins ES. Towards implantable glucose sensors: a review. J Biomed Eng. 1989;11:354-361.
21. Fischer U. Fundamentals of glucose sensors. Diabetic Med. 1991;8:309-321.
22. Kerner W, Kiwit M, Linke B, Keck F, Zier H, Pfeiffer EF. The function of a hydrogen peroxide-detecting electroenzymatic glucose sensor is markedly impaired in human subcutaneous tissue and plasma. Biosens Bioelectr. 1993;8:473-482.
23. Fraser DM. Biosensors in the Body. Continuous In Vivo Monitoring. Chichester: John Wiley & Sons; 1997.
24. Abel P, Muller A, Fischer U. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell. Biomed Biochim Acta. 1984;43:577-584.
25. 2-electrode as an approach to implantable glucose sensors. Horm Metab Res Suppl. 1988;20:26-29.
26. Shichiri M, Kawamori R, Yamasaki Y. The development of artificial endocrine pancreas. Med Prog Technol. 1987;12:39-50.
27. Rebrin K, Fischer U, von Woedtke T, Abel P, Brunstein E. Automated feedback control of subcutaneous glucose concentration in diabetic dogs. Diabetologia. 1989; 32:573-576.
28. Pickup JC, Shaw GW, Claremont DJ. In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer. Diabetologia. 1989;32:213-217.
29. Moatti-Sirat D, Capron F, Poitout V, Reach G, Bindra DS, Zhang Y, Wilson GS, Thevenot-DR. Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue. Diabetologia. 1992;35:224-230.
30. Moatti-Sirat D, Vehlo G, Reach G. Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor. Biosens Bioelectr. 1992;7:345-352.
31. Moatti-Sirat D, Poitout V, Thome V, Gangnerau MN, Zhang Y, Hu Y, Wilson GS, Lemonnier F, Klein JC, Reach G. Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man. Diabetologia. 1994;37:610-616.
32. Poitout V, Moatti-Sirat D, Reach G, Wilson GS, Lemonnier F, Klein JC. A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia. 1993;36:658-663.
33. Poitout V, Moatti D, Vehlo G, Reach G, Sternberg R, Thevenot DR, Bindra DS, Zhang Y, Wilson GS. In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor. ASAIO Trans. 1991;37:M298-M300.
34. Poitout V, Moatti-Sirat D, Reach G. Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination. Biosens Bioelectr. 1992;7:587-592.
35. Johnson KW, Mastrototaro JJ, Howey DC, Brunelle RL, Burden-Brady PL, Bryan NA, Andrew CC, Rowe HM, Allen DJ, Noffke BW, McMahan WC, Morff RJ, Lipson D, Nevin RS. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosens Bioelectr. 1992;7:709-714.
36. Von Woedtke T, Fischer U, Brunstein E, Rebrin K, Abel P. Implantable glucose sensors: comparison between in vitro and in vivo kinetics. Int J Artif Organs. 1991;14:473-481.
37. Velho G, Froguel P, Thevenot DR, Reach G. In vivo calibration of a subcutaneous glucose sensor for determination of subcutaneous glucose kinetics. Diabetes Nutr Metab. 1988;3:227-233.
38. Pfeiffer EF, Meyerhoff C, Bischof F, Keck FS, Kerner W. On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucose sensor with microdialysis. Horm Metab Res. 1993;25:121-124.
39. Koudelka M, Rohner-Jeanrenaud F, Terrettaz J, Bobbioni-Harsch E, de Rooij NF, Jeanrenaud B. In vivo response of microfabricated glucose sensors to glycaemia changes in normal rats. Biomed Biochim Acta. 1989;48:953-956.
40. Koudelka M, Rohner-Jeanrenaud F, Terrettaz J, Bobbioni-Harsch E, de Rooij NF, Jeanrenaud B. In vivo behaviour of hypodermically implanted microfabricated glucose sensors. Biosens Bioelectr. 1991;6:31-36.
41. Bobbioni-Harsch E, Rohner-Jeanrenaud F, Koudelka M, de Rooij N, Jeanrenaud B. Lifespan of subcutaneous glucose sensors and their performances during glycaemia changes in rats. J Biomed Eng. 1993;15:457-463.
42. Sternberg R, Barrau MB, Gangiotti L, Thevenot DR, Bindra DS, Wilson GS, Vehlo G, Froguel P, Reach G. Study and development of multilayer needle-type enzyme-based glucose microsensors. Biosensors. 1988;4:27-40.
43. Velho G, Froguel P, Thevenot DR, Reach G. Strategies for calibrating a subcutaneous glucose sensor. Biomed Biochim Acta. 1989;48:957-964.
44. Von Woedtke T, Rebrin K, Fischer U, Abel P, Wilke W, Vogt L, Albrecht G. In situ calibration of implanted electrochemical glucose sensors. Biomed Biochim Acta. 1989;48:943-952.
45. Park JB, Lakes RS. Biomaterials, An Introduction. 2nd ed. New York: Plenum Press; 1992.
46. Williams DF. Tissue-biomaterial interactions. J Mater Sci. 1987;22:3421-3445.
47. Spector M, Cease C, Tong-Li X. The local tissue response to biomaterials. Crit Rev Biocompatibility. 1989;5(3):269-295.
48. Remes A, Williams DF. Immune response in biocompatibility. Biomaterials. 1992;13(11):731-743.
49. Brash JL, Wojciechowski PW. Interfacial Phenomena and Bioproducts. New York: Marcel Dekker; 1996.
50. Horbett TA, Brash JL. Proteins at Interfaces: Fundamentals and Applications. Washington, DC: American Chemical Society; 1995.
51. Shichiri M, Kawamori R, Hakui N, Asakawa N, Yamasaki Y, Abe H. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus. Biomed Biochim Acta. 1984;5:561-568.
52. Shichiri M, Yamasaki Y, Nao K, Sekiya M, Ueda N. In vivo characteristics of needle-type glucose sensor: measurements of subcutaneous glucose concentrations in human volunteers. Horm Metab Res Suppl. 1988;20:17-20.
53. Muller A, Abel P, Fischer U. Continuous monitoring of subcutaneous glucose concentration using implanted enzyme electrodes. Biomed Biochim Acta. 1986;45:769-777.
54. Brunstein E, Abel P, Gens A, Eich K, von Woedtke T. Preparation and validation of implantable electrodes for the measurement of oxygen and glucose. Biomed Biochim Acta. 1989;48:911-917.
55. Rigby GP, Crump P, Vadgama P. Open flow microperfusion: approach to in vivo glucose monitoring. Med Biol Eng Comput. 1995;33:231-234.
56. Rigby GP, Crump P, Vadgama P. Stabilized needle electrode system for in vivo glucose monitoring based on open flow microperfusion. Analyst. 1996;121:871-875.
57. Labow RS, Erfle DJ, Santerre JP. Neutrophil-mediated degradation of segmented polyurethanes. Biomaterials. 1995;16:51-59.
58. Wilson R, Turner APF. Glucose oxidase: an ideal enzyme. Biosens Bioelectr. 1992;7:165-185.
59. Rebrin K, Fischer U, Hahn von Dorsche H, von Woetke T, Abel P, Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J Biomed Eng. 1992;14:33-40.
60. Updike SJ, Shults M, Ekman B. Implanting the glucose enzyme electrode: problems, progress, and alternative solutions. Diabetes Care. 1982;5(3):207-212.
61. Fischer U, Hidde A, Herrmann S, von Woedtke T, Rebrin K, Abel P. Oxygen tension at the subcutaneous implantation site of glucose sensors. Biomed Biochim Acta. 1989;48:965-971.
62. Zhang Y, Wilson GS. In vitro and in vivo evaluation of oxygen effects on a glucose oxidase based implantable glucose sensor. Anal Chim Acta. 1993;281:513-520.
63. Bessman SP, Thomas LJ, Koijma H, Sayler DF, Layne EC. The implantation of a closed-loop artificial beta cell in dogs. Trans Am Soc Artif Intern Organs. 1981;27:7-17.
64. Reach G, Feijen J, Alcock A. BIOMED concerted action chemical sensors for in vivo monitoring. The biocompatibility issue. Biosens Bioelectr. 1994;9(6):21-28.
65. Woodward SC. How fibroblasts and giant cells encapsulate implants: considerations in design of glucose sensors. Diabetes Care. 1982;5:278-281.
66. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. 1. Diffusion properties. J Biomed Mater Res. 1997;37:401-412.
67. Chang KW, Aisenberg S, Soeldner JS, Hiebert JM. Validation and bioengineering aspects of an implantable glucose sensor. Trans Am Soc Artif Intern Organs. 1973;19:352-360.
68. Shichiri M, Yamasaki Y, Kawamori R, Hakui N. Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet. 1982;20:1129-1130.
69. Shichiri M, Asakawa N, Yamasaki Y, Kawamori R, Abe H. Telemetry glucose monitoring device with needle-type glucose sensor: a useful tool for blood glucose monitoring in diabetic individuals. Diabetes Care. 1986;9:298-301.
70. Shichiri M, Kawamori R, Goriya Y, Yamasaki Y, Nomura M, Hakui N, Abe H. Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas. Diabetologia. 1983;24:179-184.
71. Nishida K, Sakakida M, Ichinose K, Uemura T, Uehara M, Kajiwara K, Miyata T, Shichiri M, Ishihara K, Nakabayashi N. Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholineco-n-butyl methacrylate. Med Prog Technol. 1995;21:91-103.
72. Claremont DJ, Sambrook IE, Penton C, Pickup JC. Subcutaneous implantation of a ferrocene-mediated glucose sensor in pigs. Diabetologia. 1986;29:817-821.
73. Pickup JC, Claremont DJ, Shaw GW. Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man. Acta Diabetologia. 1993;30:143-148.
74. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H. Closed-loop glycaemic control with a wearable artificial endocrine pancreas: variations in daily insulin requirements to glycaemic response. Diabetes. 1984;33:1200-1202.
75. Bruckel J, Kerner W, Zier H, Steinbach G, Pfeiffer EF. In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr. 1989;67:491-495.
76. Fischer U, Ertle R, Abel P, Brunstein E, Hahn von Dorsche H, Freyse EJ. Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetotogia. 1987;30:940-945.
77. Fischer U, Ertle R, Rebrin K, Freyse EJ. Wick technique: reference method for implanted glucose sensors. Artif Organs. 1989;13:453-458.
78. Vehlo G, Froguel P, Sternberg R, Thevenot DR, Reach G. In vitro and in vivo stability of electrode potentials in needle-type glucose sensors. Influence of needle material. Diabetes. 1989;38:164-171.
79. McKean BD, Gough DA. A telemetry-instrumentation system for chronically implanted glucose and oxygen sensors. IEEE Trans Biomed Eng. 1988;35:526-532.
80. Matthews DR, Bown E, Beck TW, Plotkin E, Lock L, Gosden E, Wickham M. An amperometric needle-type glucose sensor tested in rats and man. Diabetic Med. 1988;5:248-252.
81. Quinn CP, Pishko MV, Schmidtke DW, Ishikawa M, Wagner JG, Raskin P, Hubbell JA, Heller A. Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensors. Am J Physiol. 1995;269:E155-E161.
82. Linke B, Kerner W, Kiwit M, Pishko M, Heller A. Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosens Bioelectr. 1994;9:151-158.
83. Clark LC Jr, Duggan CA. Implanted electroenzymatic glucose sensors. Diabetes Care. 1982;5(3):174-180.